Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG: 3613)

Beijing Tong Ren Tang Chinese Medicine Company Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	6,186	10,162	9,593	11,234	6,822	9,844
Market Cap Growth	-37.17%	5.93%	-14.61%	64.66%	-30.70%	-4.55%
Enterprise Value	4,691	7,971	7,478	9,519	5,203	7,706
Last Close Price	7.39	11.72	10.84	12.03	7.18	10.13
PE Ratio	12.52	18.16	14.05	16.56	11.08	15.25
PS Ratio	4.49	6.66	5.54	7.22	5.19	6.87
PB Ratio	1.63	2.53	2.57	3.17	2.18	3.56
P/FCF Ratio	-19.66	23.15	18.85	14.90	66.12	18.43
P/OCF Ratio	-21.09	22.05	17.52	14.45	58.79	17.87
EV/Sales Ratio	3.41	5.23	4.32	6.12	3.96	5.38
EV/EBITDA Ratio	7.50	12.47	9.13	12.10	7.81	11.33
EV/EBIT Ratio	8.63	12.81	9.29	12.33	8.08	11.82
EV/FCF Ratio	-12.23	18.16	14.69	12.63	50.43	14.43
Debt / Equity Ratio	0.03	0.03	0.03	0.04	0.03	0.04
Debt / EBITDA Ratio	0.21	0.19	0.12	0.15	0.15	0.14
Debt / FCF Ratio	-0.35	0.30	0.20	0.17	1.03	0.19
Asset Turnover	0.33	0.35	0.43	0.43	0.40	0.45
Inventory Turnover	0.36	0.64	1.29	0.94	0.89	1.49
Quick Ratio	9.48	8.55	7.66	13.31	11.14	7.49
Current Ratio	16.79	11.65	8.80	15.38	13.54	8.61
Return on Equity (ROE)	13.83%	15.22%	19.00%	19.54%	19.27%	19.93%
Return on Assets (ROA)	8.22%	8.98%	12.48%	13.31%	12.27%	12.92%
Return on Capital (ROIC)	8.64%	9.73%	13.39%	13.98%	13.19%	13.83%
Earnings Yield	7.99%	5.32%	6.73%	5.41%	7.95%	5.65%
FCF Yield	-6.20%	4.32%	5.31%	6.71%	1.51%	5.42%
Dividend Yield	4.40%	2.82%	3.05%	2.33%	3.34%	2.27%
Payout Ratio	55.90%	51.12%	36.29%	33.05%	35.49%	34.62%
Total Shareholder Return	4.40%	2.82%	3.05%	2.33%	3.34%	2.27%

Source: S&P Capital IQ. Standard template. Financial Sources.